Hold your breath – save your heart?

Image source: Shutterstock/Peshkova

Hyperventilation vs cardiac arrhythmia

Hold your breath – save your heart?

A technique that enables patients suffering from heart conditions to hold their breath safely for over 5 minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.

In a new study, published in Frontiers in Physiology, researchers initially proposed the technique as a new means for earlier diagnosis of ischaemic heart disease. The technique involves hyperventilating conscious, unmedicated patients using a mechanical ventilator which delivers air to the patient via a face mask. Hyperventilation causes hypocapnia that leads to temporary constriction in the coronary arteries. The researchers were initially exploring whether this effect could be exploited as an ‘early warning system’ to diagnose coronary heart disease.

The fact that patients with angina were able to tolerate mechanical hyperventilation so well confirms its potential to improve the newly emerging procedure of using radiotherapy for cardiac ablation

Michael Parkes

Although more work needs to be done on its diagnostic potential, the research was able to confirm that mechanical hyperventilation and hypocapnia were well tolerated and safe for patients with angina. The team believe this paves the way to induce breath-holds of over five minutes to support an emerging new technique in which radiotherapy, instead of radiofrequency or freezing, is used for cardiac ablation.

In this procedure, patients with arrhythmias undergo precisely targeted radiotherapy, applied from outside the chest, to destroy tissue that is allowing incorrect electrical signals to cause an abnormal heart rhythm. Breathing is a problem because each breath causes the heart to move within the chest.

Lead author Dr Michael Parkes, of the University’s School of Sport, Exercise and Rehabilitation Sciences, explained: “There is still little awareness of the simplicity, availability, and safety of non-invasive mechanical hyperventilation. We have already shown that patients with breast cancer can breath-hold safely for over 5 minutes using this technique. The fact that patients with angina were able to tolerate mechanical hyperventilation so well confirms its potential to improve the newly emerging procedure of using radiotherapy for cardiac ablation. Stopping breathing with a safe breath-hold of over 5 minutes, using mechanically induced hypocapnia and now with oxygen enriched air, could allow surgeons to target the radiotherapy for cardiac ablation much more precisely. The advantage of radiotherapy over radiofrequency or freezing is that radiotherapy is completely non-invasive and is applied from outside the chest. Whereas the other techniques require a catheter, passed via a vein in the groin or artery in the neck, to be placed inside the atria in the heart. Currently such radiotherapy is being considered only when all other ablation and pharmacological techniques have failed.”

The next step is to test this technique in patients with cardiac arrhythmias  to see if they too can hold their breath long enough to apply the radiotherapy.


Source: University of Birmingham

20.01.2020

Read all latest stories

Related articles

Photo

Prognosis

Better heart failure outcomes through biomarker-based treatment

In a recent study by University of Alabama at Birmingham researchers, findings indicate that among patients with heart failure, obesity is associated with a higher risk of heart failure…

Photo

Subsidiary atrial pacemaker

Researchers discover natural 'backup pacemaker' in the heart

Researchers at The University of Manchester and Manchester University NHS Foundation Trust have discovered a backup natural pacemaker, which is able to generate a pulse and control the heart rate.…

Photo

Curbing collaterals

High energy radiotherapy ‘paints’ tumours, avoids healthy tissue

A radiotherapy technique which ‘paints’ tumours by targeting them precisely, and avoiding healthy tissue, has been devised in research led by the University of Strathclyde. Researchers used a…

Related products

Lifotronic - FA-160 Immunofluorescence Analyzer

Other

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Subscribe to Newsletter